These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25600703)

  • 1. Four types of ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: classification of IBTR based on precise pathological examination.
    Sakai T; Nishimura S; Ogiya A; Tanabe M; Kimura K; Morizono H; Iijima K; Miyagi Y; Makita M; Ito Y; Oguchi M; Horii R; Akiyama F; Iwase T
    Pathol Int; 2015 Mar; 65(3):113-8. PubMed ID: 25600703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Tanaka-Akashi S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Breast Cancer; 2005; 12(2):104-11. PubMed ID: 15858440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy.
    Panet-Raymond V; Truong PT; McDonald RE; Alexander C; Ross L; Ryhorchuk A; Watson PH
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):409-17. PubMed ID: 21288654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
    Huang E; Buchholz TA; Meric F; Krishnamurthy S; Mirza NQ; Ames FC; Feig BW; Kuerer HM; Ross MI; Singletary SE; McNeese MD; Strom EA; Hunt KK
    Cancer; 2002 Nov; 95(10):2059-67. PubMed ID: 12412158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.
    Yi M; Buchholz TA; Meric-Bernstam F; Bedrosian I; Hwang RF; Ross MI; Kuerer HM; Luo S; Gonzalez-Angulo AM; Buzdar AU; Symmans WF; Feig BW; Lucci A; Huang EH; Hunt KK
    Ann Surg; 2011 Mar; 253(3):572-9. PubMed ID: 21209588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment.
    Yoshida T; Takei H; Kurosumi M; Ninomiya J; Ishikawa Y; Hayashi Y; Tozuka K; Oba H; Kawanowa K; Inoue K; Tabei T
    Breast J; 2010; 16(2):127-33. PubMed ID: 20030655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: new primary cancer allows a good prognosis.
    Nishimura S; Takahashi K; Akiyama F; Oguchi M; Tada K; Makita M; Iwase T; Yoshimoto M; Yamashita T; Sakamoto G; Kasumi F
    Breast Cancer; 2005; 12(2):112-7. PubMed ID: 15858441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CIH-Tokyo experience with breast-conserving surgery without radiotherapy: 6.5 year follow-up results of 1462 patients.
    Kasumi F; Takahashi K; Nishimura S; Iijima K; Miyagi U; Tada K; Makita M; Iwase T; Oguchi M; Yamashita T; Akiyama F; Sakamoto G
    Breast J; 2006; 12(5 Suppl 2):S181-90. PubMed ID: 16958999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.
    Laird J; Lok B; Siu C; Cahlon O; Khan AJ; McCormick B; Powell SN; Cody H; Wen HY; Ho A; Braunstein LZ
    Ann Surg Oncol; 2018 Jan; 25(1):154-163. PubMed ID: 29094250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of XRCC4 expression by breast cancer cells on ipsilateral recurrence after breast-conserving therapy.
    Kitagawa M; Someya M; Hasegawa T; Mikami T; Asaishi K; Hasegawa T; Matsumoto Y; Kutomi G; Takemasa I; Sakata KI
    Strahlenther Onkol; 2019 Jul; 195(7):648-658. PubMed ID: 30997540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].
    Sun GY; Wang SL; Tang Y; Jin J; Song YW; Liu YP; Wang WH; Fang H; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):352-358. PubMed ID: 29860762
    [No Abstract]   [Full Text] [Related]  

  • 14. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation.
    Alpert TE; Kuerer HM; Arthur DW; Lannin DR; Haffty BG
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):845-51. PubMed ID: 16199315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S; Kestin LL; Goldstein NS; Vicini FA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials.
    Wapnir IL; Anderson SJ; Mamounas EP; Geyer CE; Jeong JH; Tan-Chiu E; Fisher B; Wolmark N
    J Clin Oncol; 2006 May; 24(13):2028-37. PubMed ID: 16648502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second invasive breast cancers in patients treated with breast-conserving therapy.
    Wang J; Tang H; Yin K; Li X; Xie X; Hughes KS
    Eur J Surg Oncol; 2021 Oct; 47(10):2492-2498. PubMed ID: 34134902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early response to neo-adjuvant chemotherapy in carcinoma of the breast predicts both successful breast-conserving surgery and decreased risk of ipsilateral breast tumor recurrence.
    Ishitobi M; Komoike Y; Motomura K; Koyama H; Inaji H
    Breast J; 2010; 16(1):9-13. PubMed ID: 19929889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancer.
    Yoshida T; Takei H; Kurosumi M; Ninomiya J; Ishikawa Y; Hayashi Y; Tozuka K; Oba H; Inoue K; Tabei T
    Breast; 2009 Aug; 18(4):238-43. PubMed ID: 19625190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence.
    Okumura Y; Nishimura R; Nakatsukasa K; Yoshida A; Masuda N; Tanabe M; Shien T; Tanaka S; Arima N; Komoike Y; Taguchi T; Iwase T; Inaji H; Ishitobi M;
    Eur J Surg Oncol; 2015 Apr; 41(4):548-52. PubMed ID: 25682910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.